MELISSA MCBRIDE: Open Payments
NPI 1629601042 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 115 payments from 14 companies in 2025. Trend: 2023 $1,465 · 2024 $1,870 · 2025 $1,933
Food & beverage: $1,821Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $330 |
| Neurocrine BioSciences, Inc. | 21 | $299 |
| Teva Pharmaceuticals USA, Inc. | 16 | $286 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $256 |
| Otsuka America Pharmaceutical, Inc. | 11 | $166 |
| E.R. Squibb & Sons, L.L.C. | 10 | $164 |
| Axsome Therapeutics, Inc. | 7 | $117 |
| Alkermes, Inc. | 6 | $105 |
| Janssen Pharmaceuticals, Inc | 3 | $77 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, COBENFY, REXULTI, Auvelity, ARISTADA, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
